Abstract
Improved methods for diagnosing small B-cell lymphomas (SBCLs) and predicting patient response to therapy are likely to result from the ongoing discovery of molecular markers that better define these malignancies. In this report, we identify 120 genes whose expression patterns differed between reactive lymph node tissue and three types of SBCL: follicular lymphoma, mantle cell lymphoma, and chronic lymphocytic leukemia/small lymphocytic lymphoma. Whereas previously published studies have generally analyzed the gene expression profiles of one type of SBCL, work presented in this paper was intended to identify genes that are differentially expressed between three SBCL subtypes. This analysis was performed using mRNA pooled from multiple specimens representing each tissue type. Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) was used to validate the differential expression of 23 of these genes. Among the 23 validated genes were cyclin D1 (CCND1) and B-cell CLL/lymphoma 2, which have well-known roles in lymphoma pathogenesis. The remaining 21 genes have no currently established role in lymphoma development. Using qRT-PCR, the expression of CCND1 and seven additional genes was further studied in a panel of individual specimens. Genes identified in this study are of biological interest and represent candidate diagnostic markers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Jemal A, Thomas A, Murray T, Thun M . Cancer statistics, 2002. CA Cancer J Clin 2002; 52: 23–47.
Ries L, Miller B, Hankey BE . SEER Cancer Statistics Review, 1973–1991: Tables and Graphs. Bethesda, MD: National Cancer Institute, 1994, Report No.: NIH Pub. No. 94-2789.
Voliotis D, Diehl V . Challenges in treating hematologic malignancies. Semin Oncol 2002; 29 (Suppl 8): 30–39.
Horning SJ . Follicular lymphoma: have we made any progress? Ann Oncol 2000; 11 (Suppl 1): 23–27.
Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML et al. A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392.
Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting – Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849.
Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J . Lymphoma classification – from controversy to consensus: the REAL and WHO classification of lymphoid neoplasms. Ann Oncol 2000; 11 (Suppl 1): 3–10.
Schena M, Shalon D, Davis RW, Brown PO . Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270: 467–470.
Husson H, Carideo EG, Neuberg D, Schultze J, Munoz O, Marks PW et al. Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays. Blood 2002; 99: 282–289.
Hofmann WK, de Vos S, Tsukasaki K, Wachsman W, Pinkus GS, Said JW et al. Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray. Blood 2001; 98: 787–794.
Zhu Y, Hollmen J, Raty R, Aalto Y, Nagy B, Elonen E et al. Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma. Br J Haematol 2002; 119: 905–915.
Ek S, Hogerkorp CM, Dictor M, Ehinger M, Borrebaeck CA . Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells. Cancer Res 2002; 62: 4398–4405.
Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003; 3: 185–197.
Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001; 194: 1639–1647.
Stratowa C, Loffler G, Lichter P, Stilgenbauer S, Haberl P, Schweifer N et al. cDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking. Int J Cancer 2001; 91: 474–480.
Klein U, Tu Y, Stolovitzky GA, Mattioli M, Cattoretti G, Husson H et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 2001; 194: 1625–1638.
Davis RE, Brown KD, Siebenlist U, Staudt LM . Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 2001; 194: 1861–1874.
Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 1937–1947.
Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503–511.
Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 2002; 8: 68–74.
Lossos IS, Alizadeh AA, Rajapaksa R, Tibshirani R, Levy R . HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma. Blood 2003; 101: 433–440.
Thieblemont C, Chettab K, Felman P, Callet-Bauchu E, Traverse-Glehen A, Berger F et al. Identification and validation of seven genes, as potential markers, for the differential diagnosis of small B cell lymphomas (small lymphocytic lymphoma, marginal zone B cell lymphoma and mantle cell lymphoma) by cDNA macroarrays analysis. Leukemia 2002; 16: 2326–2329.
Sambrook J, Fritsche E, Maniatis T . Molecular Cloning: A Laboratory Manual, 2nd edn Plainview, NY: Cold Spring Harbor Laboratory Press, 1989.
Geiss GK, An MC, Bumgarner RE, Hammersmark E, Cunningham D, Katze MG . Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events. J Virol 2001; 75: 4321–4331.
Lennon G, Auffray C, Polymeropoulos M, Soares MB . The IMAGE Consortium: an integrated molecular analysis of genomes and their expression. Genomics 1996; 33: 151–152.
Kenworthy AK . Imaging protein–protein interactions using fluorescence resonance energy transfer microscopy. Methods 2001; 24: 289–296.
Diehn M, Sherlock G, Binkley G, Jin H, Matese JC, Hernandez-Boussard T et al. SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Res 2003; 31: 219–223.
Hubbard T, Barker D, Birney E, Cameron G, Chen Y, Clark L et al. The Ensembl genome database project. Nucleic Acids Res 2002; 30: 38–41.
Eisen M, Spellman P, Brown P, Botstein D . Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863–14868.
Bjarnason R, Wickelgren R, Hermansson M, Hammarqvist F, Carlsson B, Carlsson LM . Growth hormone treatment prevents the decrease in insulin-like growth factor I gene expression in patients undergoing abdominal surgery. J Clin Endocrinol Metab 1998; 83: 1566–1572.
Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, Szabo M et al. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 2002; 94: 513–521.
Rajeevan MS, Vernon SD, Taysavang N, Unger ER . Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR. J Mol Diagn 2001; 3: 26–31.
Taylor E, Cogdell D, Coombes K, Hu L, Ramdas L, Tabor A et al. Sequence verification as quality-control step for production of cDNA microarrays. Biotechniques 2001; 31: 62–65.
Rhodes DR, Barrette TR, Rubin MA, Ghosh D, Chinnaiyan AM . Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res 2002; 62: 4427–4433.
Nelson PS . Identifying immunotherapeutic targets for prostate carcinoma through the analysis of gene expression profiles. Ann NY Acad Sci 2002; 975: 232–246.
Tsujimoto Y, Yunis J, Onorato-Showe L, Erikson J, Nowell PC, Croce CM . Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 1984; 224: 1403–1406.
Tsujimoto Y, Jaffe E, Cossman J, Gorham J, Nowell PC, Croce CM . Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature 1985; 315: 340–343.
Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ . Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334–336.
Vaux DL, Cory S, Adams JM . Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440–442.
Mathas S, Hinz M, Anagnostopoulos I, Krappmann D, Lietz A, Jundt F et al. Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B. EMBO J 2002; 21: 4104–4113.
Pan Z, Shen Y, Du C, Zhou G, Rosenwald A, Staudt LM et al. Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells. Am J Pathol 2003; 163: 135–144.
Christoph T, Rickert R, Rajewsky K . M17: a novel gene expressed in germinal centers. Int Immunol 1994; 6: 1203–1211.
Davies J, Badiani P, Weston K . Cooperation of Myb and Myc proteins in T cell lymphomagenesis. Oncogene 1999; 18: 3643–3647.
Jones PA, Laird PW . Cancer epigenetics comes of age. Nat Genet 1999; 21: 163–167.
Melki JR, Clark SJ . DNA methylation changes in leukaemia. Semin Cancer Biol 2002; 12: 347–357.
Erlanson M, Gronlund E, Lofvenberg E, Roos G, Lindh J . Expression of activation markers CD23 and CD69 in B-cell non-Hodgkin's lymphoma. Eur J Haematol 1998; 60: 125–132.
Acknowledgements
This work was supported by Washington Technology Center grant number F01-B10 and by research funding from RationalDiagnostics, Inc. to DES. SCS was supported in part by NIH training Grant 5T32HL007312-25.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schmechel, S., LeVasseur, R., Yang, KJ. et al. Identification of genes whose expression patterns differ in benign lymphoid tissue and follicular, mantle cell, and small lymphocytic lymphoma. Leukemia 18, 841–855 (2004). https://doi.org/10.1038/sj.leu.2403293
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403293
Keywords
This article is cited by
-
Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring
Diagnostic Pathology (2012)
-
Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia
Leukemia (2009)
-
Pathway-specific apoptotic gene expression profiling in chronic lymphocytic leukemia and follicular lymphoma
Modern Pathology (2006)